Last reviewed · How we verify
Placebo of Hydrocortisone
A placebo formulation containing no active hydrocortisone that serves as a control comparator in clinical trials.
A placebo formulation containing no active hydrocortisone that serves as a control comparator in clinical trials. Used for Control comparator in clinical trials (specific indication depends on parent hydrocortisone trial).
At a glance
| Generic name | Placebo of Hydrocortisone |
|---|---|
| Sponsor | Rennes University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
This is an inert placebo preparation used in randomized controlled trials to compare against active hydrocortisone treatment. It contains no pharmacologically active ingredient and produces no direct therapeutic effect, allowing researchers to isolate the true clinical benefit of hydrocortisone by controlling for placebo response and natural disease progression.
Approved indications
- Control comparator in clinical trials (specific indication depends on parent hydrocortisone trial)
Common side effects
Key clinical trials
- Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin (PHASE2)
- PTSD Prevention Using Oral Hydrocortisone (PHASE2)
- Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency (PHASE4)
- Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2) (PHASE1)
- Plant Protein With Ashwagandha-Rhodiola for Sleep Quality (NA)
- Adjunctive Fludrocortisone in Septic Shock (PHASE2)
- Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery (NA)
- Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of Hydrocortisone CI brief — competitive landscape report
- Placebo of Hydrocortisone updates RSS · CI watch RSS
- Rennes University Hospital portfolio CI